Evaluating a new treatment for tuberculosis
EPCTU: A Study to Evaluate the Pharmacokinetics and Safety of a Therapeutic for Tuberculosis
This study is looking at a new medication for tuberculosis to see how well it works and if it's safe for people with the condition, and you'll be helping us learn more by trying it out in a clinical trial.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icon Government and Public Health Solutions, INC. NIH-funded |
| Lab location | 1 site (Hinckley, United States) |
| Project ID | NIH-10912971 on NIH RePORTER |
What this research studies
This research investigates the pharmacokinetics and safety of a new therapeutic agent aimed at treating tuberculosis. Patients will receive the treatment, and researchers will closely monitor how the drug is absorbed, distributed, metabolized, and excreted in the body. The study aims to ensure that the new therapy is both effective and safe for individuals suffering from tuberculosis. Participants will be involved in a clinical trial that assesses various aspects of the treatment's performance.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with tuberculosis who are seeking new treatment options.
Not a fit: Patients who do not have tuberculosis or those who are not eligible for clinical trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer treatments for tuberculosis, improving patient outcomes.
How similar studies have performed: Other research has shown success in evaluating new treatments for tuberculosis, indicating that this approach is promising.
Where this research is happening
Hinckley, United States
- Icon Government and Public Health Solutions, INC. — Hinckley, United States (Active)
Researchers
- Principal investigator: Spitz, Robert — Icon Government and Public Health Solutions, INC.
- Study coordinator: Spitz, Robert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.